1st Quarter - Report

BROWN RUDNICK LLP for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues relating to prescription drug abuse in the Medicare Part D prescription drug program. Implementation of the Biologics Price Competition and Innovation Act (BPCIA)

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

HR 793 - Ensuring Seniors Access to Local Pharmacies Act

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 793 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.